{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:18:30Z","timestamp":1786990710997,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002999","name":"Ministerie van Volksgezondheid, Welzijn en Sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ijid.2025.108264","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T16:06:23Z","timestamp":1764345983000},"page":"108264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Longitudinal trends in the endemic symptomatic burden of COVID-19: Insights from community-based participatory virological surveillance in the Netherlands, November 2020-April 2025"],"prefix":"10.1016","volume":"163","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2863-2521","authenticated-orcid":false,"given":"Gesa","family":"Carstens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Timmermanns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"van den Hof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Eggink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert Jan","family":"van Hoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2025.108264_bib0001","article-title":"Darwin review: the evolution of virulence in human pathogens","volume":"291","author":"Gupta","year":"2024","journal-title":"Proc R Soc B Biol Sci"},{"key":"10.1016\/j.ijid.2025.108264_bib0002","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","article-title":"The evolution of SARS-CoV-2","volume":"21","author":"Markov","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijid.2025.108264_bib0003","unstructured":"National Institute for Public Health and the Environment (RIVM), Tijdlijnen COVID-19 (2025). https:\/\/tijdlijnencovid19.rivm.nl\/thema\/Vaccinaties (Accessed 8 May 2025)."},{"key":"10.1016\/j.ijid.2025.108264_bib0004","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12879-025-10509-1","article-title":"Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China","volume":"25","author":"Qiu","year":"2025","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2025.108264_bib0005","doi-asserted-by":"crossref","DOI":"10.1093\/eurpub\/ckae144.505","article-title":"Excess mortality in individuals with and without COVID-19 vaccination in the Netherlands in 2021","volume":"34","author":"Rijpkema","year":"2024","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.ijid.2025.108264_bib0006","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s41999-024-01002-0","article-title":"Differences in characteristics and outcomes of older patients hospitalized for COVID-19 after introduction of vaccination","volume":"15","author":"Smits","year":"2024","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.ijid.2025.108264_bib0007","unstructured":"Infectieradar, (n.d.). https:\/\/www.infectieradar.nl\/welcome (accessed May 8, 2025)."},{"key":"10.1016\/j.ijid.2025.108264_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0303230","article-title":"Flexible and scalable participatory syndromic and virological surveillance for respiratory infections: our experiences in The Netherlands","volume":"20","author":"Smit","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2025.108264_bib0009","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268821001187","article-title":"Risk factors associated with the incidence of self-reported COVID-19-like illness: data from a web-based syndromic surveillance system in the Netherlands","volume":"149","author":"McDonald","year":"2021","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ijid.2025.108264_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2025.106474","article-title":"Co-infection dynamics of SARS-CoV-2 and respiratory viruses in the 2022\/2023 respiratory season in the Netherlands","volume":"90","author":"Carstens","year":"2025","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2025.108264_bib0011","author":"Lenth"},{"key":"10.1016\/j.ijid.2025.108264_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fviro.2022.880707","article-title":"Changes in symptoms experienced by SARS-CoV-2-infected individuals\u2014from the first wave to the omicron variant","volume":"2","author":"Schulze","year":"2022","journal-title":"Front Virol"},{"key":"10.1016\/j.ijid.2025.108264_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25105451","article-title":"In Silico analyses indicate a lower potency for dimerization of TLR4\/MD-2 as the reason for the lower pathogenicity of Omicron compared to Wild-type virus and earlier SARS-CoV-2 variants","volume":"25","author":"Kircheis","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijid.2025.108264_bib0014","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/s41467-024-46490-7","article-title":"Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86\/JN.1 lineages combining increased fitness and antibody evasion","volume":"15","author":"Planas","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijid.2025.108264_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294897","article-title":"COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4\/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history","volume":"19","author":"Townsley","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2025.108264_bib0016","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-059130","article-title":"Changes in primary care visits arising from the COVID-19 pandemic: an international comparative study by the International Consortium of Primary Care Big Data Researchers (INTRePID)","volume":"12","author":"Tu","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijid.2025.108264_bib0017","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41533-025-00426-w","article-title":"Hasselt Corona impact study: impact of COVID-19 on healthcare seeking in a small Dutch town","volume":"35","author":"Veldman","year":"2025","journal-title":"Npj Prim Care Respir Med"},{"key":"10.1016\/j.ijid.2025.108264_bib0018","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000029439","article-title":"\u201cI am hesitant to visit the doctor unless absolutely necessary\u201d: a qualitative study of delayed care, avoidance of care, and telehealth experiences during the COVID-19 pandemic","volume":"101","author":"Moore","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijid.2025.108264_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003854","article-title":"Prevalence and determinants of healthcare avoidance during the COVID-19 pandemic: a population-based cross-sectional study","volume":"18","author":"Splinter","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2025.108264_bib0020","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1038\/s41467-022-34244-2","article-title":"Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England","volume":"13","author":"Whitaker","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijid.2025.108264_bib0021","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1473-3099(24)00574-7","article-title":"Clinical profile analysis of SARS-CoV-2 community infections during periods with omicron BA.2, BA.4\/5, and XBB dominance in Hong Kong: a prospective cohort study","volume":"25","author":"Wang","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2025.108264_bib0022","doi-asserted-by":"crossref","DOI":"10.1111\/imr.13089","article-title":"Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines","author":"Sette","year":"2022","journal-title":"Immunol Rev"},{"key":"10.1016\/j.ijid.2025.108264_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249499","article-title":"Human IgG and IgA responses to COVID-19 mRNA vaccines","volume":"16","author":"Wisnewski","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2025.108264_bib0025","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1473-3099(22)00801-5","article-title":"Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression","volume":"23","author":"Bobrovitz","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2025.108264_bib0026","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S1473-3099(24)00220-2","article-title":"Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational study","volume":"24","author":"Moustsen-Helms","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2025.108264_bib0027","article-title":"Severity of COVID-19 sub-lineages XBB\/XBB 1.5\/XBB1.16, EG.5.1. and JN.1. in England","volume":"43","author":"Quinot","year":"2024","journal-title":"Lancet Reg Health Eur"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225004862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225004862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:47:51Z","timestamp":1783018071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225004862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":26,"alternative-id":["S1201971225004862"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108264","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal trends in the endemic symptomatic burden of COVID-19: Insights from community-based participatory virological surveillance in the Netherlands, November 2020-April 2025","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108264"}}